Springer Nature AG & Co. KGaA
SPG
ISIN DE000SPG1003 / Valor 41578404
Springer Nature AG & Co. KGaA
UMushroom community rating:
About company
Springer Nature AG & Co. KGaA is a prominent global academic publishing company that specializes in providing high-quality content and services across various scientific, technical, and medical fields. Formed through the merger of Springer Science+Business Media and Macmillan Science and Education, the company is known for its extensive portfolio of journals, books, and digital resources that support researchers, educators, and professionals worldwide. Springer Nature plays a significant role in advancing discovery by offering innovative solutions and platforms that facilitate the dissemination of knowledge. The company is structured to cater to diverse research needs, with dedicated divisions focusing on research publishing, educational resources, and professional development. Through its commitment to fostering open access and supporting the global research community, Springer Nature continues to be a key player in the academic publishing industry.
Summarized from source with an LLMView SourceSector: TechnologyLatest Results (19.11.2025):
Springer Nature AG & Co. KGaA delivered robust financial results for the first nine months of 2025, demonstrating strong underlying revenue and profit growth. The company achieved a 5.9% underlying revenue increase to €1,428.7 million and a 9.9% rise in adjusted operating profit to €408.3 million, driven by strong performance in its research segment and efficient cost measures. These results, alongside improved free cash flow and a favorable leverage ratio of 1.9x, reinforce the company’s confidence in meeting its full-year 2025 guidance.
Revenue and Profit Growth
For the first nine months of 2025, Springer Nature AG & Co. KGaA reported a 5.9% underlying revenue increase to €1,428.7 million and a 9.9% growth in underlying adjusted operating profit, bolstered by operating leverage and an optimal product mix across segments.
Segment Performance
The Research segment led performance with 7.0% underlying revenue growth, especially from the journals portfolio and Full Open Access, while Health and Education segments also contributed positively, supported by efficiency measures and strategic initiatives in key markets.
Free Cash Flow and Leverage
Free cash flow improved significantly by approximately €103 million to reach €175 million, and the financial leverage ratio was reduced to 1.9x, positioning the company well for sustained financial health.
Outlook and Guidance
Springer Nature AG & Co. KGaA reaffirmed its full-year 2025 guidance, expecting revenue to be between €1,930 million and €1,960 million and adjusted operating profit between €540 million and €560 million, underpinning its strategic initiatives for continued growth.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
4430 M
Market cap (USD)
36,404
Daily traded volume (Shares)
28.3 / 27
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
